NCT02245529View on ClinicalTrials.gov

Safety Profile of Secotex ® in Patients With Benign Prostatic Hyperplasia

CompletedOBSERVATIONAL
Enrollment

982

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

September 30, 2005

Conditions
Prostatic Hyperplasia
Interventions
DRUG

Tamsulosin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02245529 - Safety Profile of Secotex ® in Patients With Benign Prostatic Hyperplasia | Biotech Hunter | Biotech Hunter